Bryan DeChairo

Bryan DeChairo

Directeur des opérations chez GENEDX HOLDINGS CORP.
53 ans
Health Technology
Health Services
Consumer Services

Profil

Bryan Michael DeChairo is currently an Independent Director at Biocartis Group NV since 2023, a Director at Sense Biodetection Ltd. since 2023, and will be Chief Operating Officer at GeneDx Holdings Corp.
starting in 2025.
Formerly, Dr. DeChairo was President, Chief Executive Officer & Director at Sherlock Biosciences, Inc. from 2021 to 2024.
Other former roles include Director-Molecular Medicine & Neuroscience Lead at Pfizer (St. Louis), Principal at Sequana Therapeutics, Inc., Executive Vice President-Clinical Development at Myriad Genetics, Inc. from 2012 to 2021, Head-Diagnostic Reimbursement Evaluation at Medco Health Solutions, Inc., Principal Scientist at Oxagen Ltd., Principal at Roche Molecular Systems, Inc., and Senior VP-Medical Affairs & Clinical Development at Assurex Health, Inc. from 2013 to 2017.
Education includes undergraduate studies at the University of California, Berkeley and a doctorate from University College London.

Postes actifs de Bryan DeChairo

SociétésPosteDébut
BIOCARTIS GROUP NV Directeur/Membre du Conseil 21/02/2023
GENEDX HOLDINGS CORP. Directeur des opérations 02/01/2025
Directeur/Membre du Conseil 30/01/2023

Anciens postes connus de Bryan DeChairo

SociétésPosteFin
Directeur Général 01/12/2024
MYRIAD GENETICS, INC. Corporate Officer/Principal 01/04/2021
Directeur Technique/Scientifique/R&D 01/08/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Bryan DeChairo

Formation de Bryan DeChairo

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

34

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Services

  1. Bourse
  2. Insiders
  3. Bryan DeChairo